Swedish Healthtech Stock News

Mycronic (OM:MYCR) is back in focus after announcing a customized SLX laser mask writer order from a new customer, valued between US$27 million and US$30 million, with delivery planned for 2028. See our latest analysis for Mycronic. The SLX mask writer order comes at a time when momentum in Mycronic’s shares is clearly building, with a 27.5% 1 month share price return and a 47.46% 1 year total shareholder return. If this kind of semiconductor exposure interests you, it could be worth widening...

Dynavox Group (OM:DYVOX) is back on investor radar after recent commentary highlighted the stock as undervalued relative to estimated future cash flows, with earnings and revenue growth expectations reported as above the Swedish market. See our latest analysis for Dynavox Group. Recent gains have been strong, with a 1 day share price return of 6.37% and a 30 day share price return of 24.72%, while the 1 year total shareholder return of 77.98% and 3 year total shareholder return of about 2.7x...

Dividend decision and board change set the tone for Husqvarna Husqvarna (OM:HUSQ B) is back on investors’ radars after its AGM approved a SEK 1.25 per share dividend for 2025 in two installments and confirmed Glen Instone as a new Board member. See our latest analysis for Husqvarna. The stock’s recent AGM news has followed a period of mixed price momentum, with a 30 day share price return of 18.75% contrasting with a year to date share price return of 10.37% and a 5 year total shareholder...

What the recent performance in Getinge (OM:GETI B) signals for investors Getinge (OM:GETI B) has drawn fresh attention after a recent share move, with the stock up about 6% over the past week and around 13% over the past month. That short term shift sits against a year to date return of about 6% decline and a past 3 months return close to 3% decline, giving investors a mixed picture of recent momentum. See our latest analysis for Getinge. At a share price of SEK203.9, the recent 1 month share...

Following the solid earnings report from Envar Holding AB (publ) ( STO:ENVAR ), the market responded by bidding up the...

Some investors rely on dividends for growing their wealth, and if you're one of those dividend sleuths, you might be...

Readers hoping to buy Synsam AB (publ) ( STO:SYNSAM ) for its dividend will need to make their move shortly, as the...

It looks like Upsales Technology AB (publ) ( STO:UPSALE ) is about to go ex-dividend in the next three days. The...

Regular readers will know that we love our dividends at Simply Wall St, which is why it's exciting to see Arjo AB...

Wihlborgs Fastigheter AB (publ) ( STO:WIHL ) is about to trade ex-dividend in the next two days. Typically, the...

Regular readers will know that we love our dividends at Simply Wall St, which is why it's exciting to see Skåne-möllan...

Readers hoping to buy FastPartner AB (publ) ( STO:FPAR A ) for its dividend will need to make their move shortly, as...

It looks like Heba Fastighets AB (publ) ( STO:HEBA B ) is about to go ex-dividend in the next 3 days. Typically, the...

Investment AB Öresund (publ) ( STO:ORES ) stock is about to trade ex-dividend in 3 days. The ex-dividend date is...

We feel now is a pretty good time to analyse Annexin Pharmaceuticals AB (publ)'s ( STO:ANNX ) business as it appears...

Swedish Orphan Biovitrum (Sobi) and partner Apellis Pharmaceuticals have received Health Canada approval for EMPAVELI (pegcetacoplan) to treat rare kidney diseases C3 glomerulopathy and primary IC-MPGN in patients aged 12 and older, based on Phase 3 VALIANT data showing reduced proteinuria, stabilized kidney function, and clearance of C3 deposits. This decision extends EMPAVELI’s nephrology footprint beyond the US and EU into Canada, adding another rare-disease indication to Sobi’s portfolio...

There's no doubt that money can be made by owning shares of unprofitable businesses. For example, although Amazon.com...

The excitement of investing in a company that can reverse its fortunes is a big draw for some speculators, so even...

AB SKF recently announced it will close its shared Automotive and Industrial factory in Monterrey, Mexico, shifting production to its Puebla and La Silla plants as part of the ongoing separation of its Automotive business and a consolidation of its Americas manufacturing footprint. This reconfiguration responds to lower-than-anticipated electric vehicle demand and aims to align capacity with each division’s needs while incurring about SEK 0.50 billion in consolidation costs and cutting...

Swedish Logistic Property (OM:SLP B) has just secured two multi year leases, including a large agreement with Essity and a deal that filled a previously vacant Malmö property, alongside reporting higher first quarter sales. See our latest analysis for Swedish Logistic Property. Recent leasing wins and the Q1 update appear to have attracted fresh attention, with a 12.33% 1 month share price return and 10.81% 1 year total shareholder return suggesting momentum has picked up despite a softer 90...

Sales update that is shaping current interest Clas Ohlson (OM:CLAS B) has just reported its March 2026 sales update, with SEK 902 million in monthly sales and SEK 11,585 million year to date, including 7% growth mainly linked to organic expansion. See our latest analysis for Clas Ohlson. The latest sales update has arrived alongside strong share price momentum, with a 10.84% 1 month share price return and a 39.04% 3 month share price return. The 1 year total shareholder return of 59.51% sits...

Bufab AB (publ) ( STO:BUFAB ) is about to trade ex-dividend in the next four days. The ex-dividend date is usually set...

Alfa Laval AB (publ) ( STO:ALFA ) is about to trade ex-dividend in the next 3 days. The ex-dividend date generally...

It looks like Nederman Holding AB (publ) ( STO:NMAN ) is about to go ex-dividend in the next 2 days. The ex-dividend...